Most Read Articles
2 years ago
Catecholamines may regulate serum HDL cholesterol level, abdominal visceral and subcutaneous fat mass in men with pheochromocytoma, based on a cross-sectional and longitudinal follow-up study.
5 days ago
There is a growing number of targeted therapies being approved for use in cancer therapy in the home setting, and this poses a potential risk among family member and caregivers, particularly those of reproductive risk age, a recent study suggests.
2 years ago

Advanced endoscopic devices can significantly improve the detection rates of colorectal polyps and tumors beyond standard colonoscopy, which has a miss rate of about 25 percent, reported speakers at the “Inventor’s Corner” session of the conference.

Christina Lau, 3 years ago

In patients with metastatic breast cancer who failed to clear circulating tumor cells (CTCs) after one cycle of first-line chemotherapy, switching to a different chemotherapy does not improve survival or delay progression, the phase III SWOG S0500 trial has shown.    

US panel finds insufficient evidence to support pelvic exams in asymptomatic women

Elvira Manzano
4 months ago

There is insufficient evidence to assess the harms and benefits of using pelvic examinations to screen for gynaecologic conditions in asymptomatic nonpregnant adult women, according to a recommendation statement issued by the US Preventive Services Task Force (USPSTF).

Pelvic examination has been a mainstay in the evaluation for infectious diseases, vulvar disorders, benign uterine pathology (leiomyoma and endometriosis), and gynaecological malignancies (cervical and vaginal cancer). The task force, which is composed of an independent panel of medical experts, investigated whether there is evidence to support this practice in the primary care setting.

“We found that there was little evidence on the accuracy of screening pelvic examinations to detect various [gynaecological] conditions,” said Dr Kirsten Bibbins-Domingo, chairman of the USPSTF and an internist at the University of California, San Francisco, US. “The evidence is either lacking, of poor quality, or conflicting to assess the benefits and harms in this population.”  [JAMA 2017;317:947-953]

Of all studies analysed, only four reported on ovarian cancer and four on various infectious diseases (2 on bacterial vaginosis, 1 on genital herpes, and 1 on trichomoniasis).

Similarly, there were no good- or fair-quality studies directly evaluating pelvic exam as a tool to improve the quality of life or to reduce disease-specific morbidity or mortality in asymptomatic women.

“This is not a recommendation against performing pelvic exams,” said Bibbins-Domingo. “At this time, there simply is not enough evidence to determine the benefits and harms of using pelvic exams to screen for conditions other than cervical cancer, chlamydia, and gonorrhoea.”

The recommendation applies to asymptomatic women 18 years of age and older who are at an average risk for gynaecologic conditions such as genital warts, trichomoniasis, uterine fibroids, and candidiasis, among others. It does not apply to screening for cervical cancer, gonorrhoea, and chlamydia, or any disorder for which the panel already recommends screening using Pap (Papanicolaou) smear, HPV test, and nucleic acid amplification tests, nor to pregnant women and adolescents.

“The recommendation of the task force appears reasonable,” said Dr Colleen P. McNicholas from the Washington University School of Medicine in St. Louis, Missouri, US and Dr Jeffrey Peipert from the Indiana University School of Medicine in Indianapolis, Indiana, US, in an editorial. However, despite the insufficiency of evidence to support or refute annual pelvic exams in asymptomatic women, it is not clear if it is time to abandon the procedure, they added. [JAMA 2017;317:910-911]

What is clear is that clinicians should not require asymptomatic women to undergo pelvic exam to obtain screening, counselling or health services. However, the procedure may be desirable in some asymptomatic cases, for example, in women who are considering intrauterine contraception or in those who seek reassurance regarding their gynaecological anatomy, said the editorialists.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
2 years ago
Catecholamines may regulate serum HDL cholesterol level, abdominal visceral and subcutaneous fat mass in men with pheochromocytoma, based on a cross-sectional and longitudinal follow-up study.
5 days ago
There is a growing number of targeted therapies being approved for use in cancer therapy in the home setting, and this poses a potential risk among family member and caregivers, particularly those of reproductive risk age, a recent study suggests.
2 years ago

Advanced endoscopic devices can significantly improve the detection rates of colorectal polyps and tumors beyond standard colonoscopy, which has a miss rate of about 25 percent, reported speakers at the “Inventor’s Corner” session of the conference.

Christina Lau, 3 years ago

In patients with metastatic breast cancer who failed to clear circulating tumor cells (CTCs) after one cycle of first-line chemotherapy, switching to a different chemotherapy does not improve survival or delay progression, the phase III SWOG S0500 trial has shown.